Viewing Study NCT01381835

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-06-16 @ 3:32 PM
Study NCT ID: NCT01381835
Status: COMPLETED
Last Update Posted: 2013-10-14
First Post: 2011-06-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TMC435-TiDP16-C126 View
None TMC435-C126 View
None TMC435 View
None HCV View
None Hepatitis C View
None Hep C View
None severe renal impairement View